Subtopical Skincare Systems

View More

Ourself Bridges the Gap Between Skincare & Clinical Procedures

Ourself is the first-ever Subtopical Skincare System and it uses biotechnology to provide clinical-level results without the clinic. Intides (intelligent peptides) and patent-pending delivery technology power the proprietary formulas to address the root of specific skincare concerns, all without needles and lasers.

The category-defining brand was conceptualized to fill the gap between traditional skincare products and clinical procedures, and offer an at-home alternative to minimally invasive cosmetic procedures. The debut products from the brand include a daily renewal cream and a mineral sunscreen, as well as solutions to address hyperpigmentation and loss of volume in the lips.

"Our clinical and user trials have shown results that, until now, could only be achieved through more invasive procedures. Our unique approach and use of biotechnology will revolutionize the skincare industry," says Ourself's President and Co-Founder Vimla Black-Gupta.
Trend Themes
1. Subtopical Skincare Systems - Innovative skincare products are using biotechnology to provide clinical-level results without surgery.
2. Minimally Invasive Cosmetic Alternatives - Products like Ourself's Subtopical Skincare System are offering a less invasive alternative to traditional cosmetic procedures.
3. Advanced Skincare Technology - The use of intelligent peptides and patent-pending delivery technology is opening up new possibilities for skincare and clinical procedures.
Industry Implications
1. Cosmetic Industry - Ourself's Subtopical Skincare System is disrupting the traditional cosmetic industry by offering a less invasive alternative to surgical procedures.
2. Skincare Industry - The skincare industry is being disrupted by the use of biotechnology and advanced delivery systems to provide clinical-level results at home.
3. Biotech Industry - Ourself's use of biotechnology and intelligent peptides in their Subtopical Skincare System is disrupting the biotech industry by opening up new applications for these technologies.

Related Ideas

Similar Ideas
VIEW FULL ARTICLE